The FDA just approved Moderna's mRNA flu vaccine for adults 50+. It's the first mRNA flu shot for flu prevention in the US, and a large trial showed it was about 27% more effective than standard shots for this age group. A promising new tool for public health.
FDA Approves First mRNA Flu Vaccine for Adults Aged 50+
The U.S. Food and Drug Administration (FDA) has granted approval to Moderna's mRNA flu vaccine, mResvia, for individuals 50 years of age and older. This marks a significant milestone as the first mRNA
krdo.com
August 16, 2026 at 2:05 PM
The FDA just approved Moderna's mRNA flu vaccine for adults 50+. It's the first mRNA flu shot for flu prevention in the US, and a large trial showed it was about 27% more effective than standard shots for this age group. A promising new tool for public health.
Canada approves Moderna’s RSV vaccine, first of its kind for older adults
globalnews.ca/news/1086036...
globalnews.ca/news/1086036...
Canada approves Moderna’s RSV vaccine, first of its kind for older adults - National | Globalnews.ca
Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.
globalnews.ca
November 8, 2024 at 3:20 PM
Canada approves Moderna’s RSV vaccine, first of its kind for older adults
globalnews.ca/news/1086036...
globalnews.ca/news/1086036...
Moderna receives expanded approval for RSV vaccine
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
www.cidrap.umn.edu/r...
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
www.cidrap.umn.edu/r...
June 13, 2025 at 7:20 PM
Moderna receives expanded approval for RSV vaccine
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
www.cidrap.umn.edu/r...
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
www.cidrap.umn.edu/r...
MODERNA RECEIVES U.S. FDA APPROVAL FOR RSV VACCINE, MRESVIA, IN ADULTS AGED 18–59 AT INCREASED RISK FOR RSV DISEASE
June 12, 2025 at 11:40 PM
MODERNA RECEIVES U.S. FDA APPROVAL FOR RSV VACCINE, MRESVIA, IN ADULTS AGED 18–59 AT INCREASED RISK FOR RSV DISEASE
The FDA has approved Moderna’s mResvia (mRNA-1345) for the prevention of RSV in people ages 18 to 59 years old who are at increased risk.
ACIP is scheduled to vote on the recommendation at the June meeting.
www.cidrap.umn.edu/respiratory-...
ACIP is scheduled to vote on the recommendation at the June meeting.
www.cidrap.umn.edu/respiratory-...
Moderna receives expanded approval for RSV vaccine
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
www.cidrap.umn.edu
June 14, 2025 at 3:24 PM
The FDA has approved Moderna’s mResvia (mRNA-1345) for the prevention of RSV in people ages 18 to 59 years old who are at increased risk.
ACIP is scheduled to vote on the recommendation at the June meeting.
www.cidrap.umn.edu/respiratory-...
ACIP is scheduled to vote on the recommendation at the June meeting.
www.cidrap.umn.edu/respiratory-...
Oh last thing- if you're pregnant and planning to get an RSV vaccine, make sure that it is Abrysvo and not Arexvy or mRESVIA. Only Abrysvo is approved for use in pregnancy.
June 25, 2025 at 8:49 PM
Oh last thing- if you're pregnant and planning to get an RSV vaccine, make sure that it is Abrysvo and not Arexvy or mRESVIA. Only Abrysvo is approved for use in pregnancy.
#RSV-Impfung älterer Erwachsener mit mRNA-RSV-Impfstoff #mRESVIA?
Für die von der STIKO empfohlene einmalige RSV-Impfung älterer Erwachsener kann künftig auch der mRNA-Impfstoff mRESVIA verwendet werden. Hat er bessere Daten als die beiden anderen RSV-Impfstoffe?
Für die von der STIKO empfohlene einmalige RSV-Impfung älterer Erwachsener kann künftig auch der mRNA-Impfstoff mRESVIA verwendet werden. Hat er bessere Daten als die beiden anderen RSV-Impfstoffe?
RSV-Impfung älterer Erwachsener mit mRNA-RSV-Impfstoff ▼mRESVIA?
Für die von der STIKO empfohlene einmalige RSV-Impfung älterer Erwachsener kann künftig auch der mRNA-Impfstoff mRESVIA verwendet werden. Hat er bessere Daten als die beiden anderen RSV-Impfstoffe?
www.arznei-telegramm.de
September 3, 2025 at 6:11 AM
#RSV-Impfung älterer Erwachsener mit mRNA-RSV-Impfstoff #mRESVIA?
Für die von der STIKO empfohlene einmalige RSV-Impfung älterer Erwachsener kann künftig auch der mRNA-Impfstoff mRESVIA verwendet werden. Hat er bessere Daten als die beiden anderen RSV-Impfstoffe?
Für die von der STIKO empfohlene einmalige RSV-Impfung älterer Erwachsener kann künftig auch der mRNA-Impfstoff mRESVIA verwendet werden. Hat er bessere Daten als die beiden anderen RSV-Impfstoffe?
And now there are 3: #FDA approves Moderna's #RSV vaccine, mResvia, for adults 60 and older.
This vaccine is Moderna's 2nd licensed product, after its Covid-19 vaccine Spikevax. It arrives on the market a year after competitors from GSK and Pfizer. www.statnews.com/2024/05/31/m...
This vaccine is Moderna's 2nd licensed product, after its Covid-19 vaccine Spikevax. It arrives on the market a year after competitors from GSK and Pfizer. www.statnews.com/2024/05/31/m...
FDA approves Moderna’s RSV vaccine, its second licensed product
The FDA approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.
www.statnews.com
May 31, 2024 at 3:06 PM
And now there are 3: #FDA approves Moderna's #RSV vaccine, mResvia, for adults 60 and older.
This vaccine is Moderna's 2nd licensed product, after its Covid-19 vaccine Spikevax. It arrives on the market a year after competitors from GSK and Pfizer. www.statnews.com/2024/05/31/m...
This vaccine is Moderna's 2nd licensed product, after its Covid-19 vaccine Spikevax. It arrives on the market a year after competitors from GSK and Pfizer. www.statnews.com/2024/05/31/m...
Okay now we have Moderna's presentation for mRESVIA (mRNA-1345), their RSV vaccine. This is an mRNA vaccine which uses the prefusion-stabilized form of the RSV F protein. The vaccine was recently approved by the FDA. This meeting should help create recommendations for its use.
June 26, 2024 at 1:37 PM
Okay now we have Moderna's presentation for mRESVIA (mRNA-1345), their RSV vaccine. This is an mRNA vaccine which uses the prefusion-stabilized form of the RSV F protein. The vaccine was recently approved by the FDA. This meeting should help create recommendations for its use.
Er zijn RSV vaccins voor 60+ en zwangeren, daar zijn verschillende fabrikanten.
GSK’s AREXVY is een recombinant RSV F eiwit vaccin (RSV-A subtype)
Pfizer’s ABRYSVO is s een recombinant RSV F eiwit vaccin (RSV-A and RSV-B)
Moderna’s mRESVIA is een mRNA-based vaccin pre-F protein (RSV-A)
3/10
GSK’s AREXVY is een recombinant RSV F eiwit vaccin (RSV-A subtype)
Pfizer’s ABRYSVO is s een recombinant RSV F eiwit vaccin (RSV-A and RSV-B)
Moderna’s mRESVIA is een mRNA-based vaccin pre-F protein (RSV-A)
3/10
January 4, 2025 at 5:51 PM
Er zijn RSV vaccins voor 60+ en zwangeren, daar zijn verschillende fabrikanten.
GSK’s AREXVY is een recombinant RSV F eiwit vaccin (RSV-A subtype)
Pfizer’s ABRYSVO is s een recombinant RSV F eiwit vaccin (RSV-A and RSV-B)
Moderna’s mRESVIA is een mRNA-based vaccin pre-F protein (RSV-A)
3/10
GSK’s AREXVY is een recombinant RSV F eiwit vaccin (RSV-A subtype)
Pfizer’s ABRYSVO is s een recombinant RSV F eiwit vaccin (RSV-A and RSV-B)
Moderna’s mRESVIA is een mRNA-based vaccin pre-F protein (RSV-A)
3/10
Die Europäische Kommission hat das RSV-Vakzin mResvia für Personen ab 60 Jahren zugelassen. mResvia ist der erste mRNA-Impfstoff, der abseits von COVID-19 zugelassen wurde.
www.aerztezeitung.de/Medizin/Erst...
germany.representation.ec.europa.eu/news/kommiss...
www.aerztezeitung.de/Medizin/Erst...
germany.representation.ec.europa.eu/news/kommiss...
Erster mRNA-Impfstoff gegen RSV in EU zugelassen
Die Europäische Kommission hat das RSV-Vakzin mResvia für Personen ab 60 Jahren zugelassen. mResvia ist der erste mRNA-Impfstoff, der in der EU für eine andere Krankheit als COVID-19 zugelassen wurde.
www.aerztezeitung.de
August 23, 2024 at 12:57 PM
Die Europäische Kommission hat das RSV-Vakzin mResvia für Personen ab 60 Jahren zugelassen. mResvia ist der erste mRNA-Impfstoff, der abseits von COVID-19 zugelassen wurde.
www.aerztezeitung.de/Medizin/Erst...
germany.representation.ec.europa.eu/news/kommiss...
www.aerztezeitung.de/Medizin/Erst...
germany.representation.ec.europa.eu/news/kommiss...
mRESVIA has been studied with coadministration with COVID-19 and flu vaccines per Moderna, with safety and immunogenicity both being acceptable, but those data are not available today.
Correlates of protection from Moderna came from their efficacy trial using over 400 cases.
Correlates of protection from Moderna came from their efficacy trial using over 400 cases.
April 16, 2025 at 3:00 PM
mRESVIA has been studied with coadministration with COVID-19 and flu vaccines per Moderna, with safety and immunogenicity both being acceptable, but those data are not available today.
Correlates of protection from Moderna came from their efficacy trial using over 400 cases.
Correlates of protection from Moderna came from their efficacy trial using over 400 cases.
the FDA has just approved a third RSV vaccine today from Moderna (mRESVIA, mRNA-1345). While the CDC has not yet made recommendations for its use, it does already have an uphill climb because it showed more rapid waning than its competitors:
www.cdc.gov/vaccines/aci...
www.cdc.gov/vaccines/aci...
May 31, 2024 at 5:39 PM
the FDA has just approved a third RSV vaccine today from Moderna (mRESVIA, mRNA-1345). While the CDC has not yet made recommendations for its use, it does already have an uphill climb because it showed more rapid waning than its competitors:
www.cdc.gov/vaccines/aci...
www.cdc.gov/vaccines/aci...
#JPM25: No acquisition of Moderna (perhaps, not yet); but the company announces $1.5 billion in cost cuts in 2025-26. The hashtag #RSV vaccine, mRESVIA, is a key development in respiratory diseases. But addressable market contracted sharply after the CDC revised its immunization guidance
January 13, 2025 at 9:27 PM
mRESVIA
#RSV -Impfstoff von Moderna ab sofort erstattungsfähig
Er kann regulär für Menschen ab 75 Jahren sowie für 60- bis 74-Jährige mit bestimmten Risikofaktoren ...
⬇️
https://www.apotheke-adhoc.de/nachrichten/detail/pharmazie/rsv-impfstoff-von-moderna-ab-sofort-erstattungsfaehig/#
#RSV -Impfstoff von Moderna ab sofort erstattungsfähig
Er kann regulär für Menschen ab 75 Jahren sowie für 60- bis 74-Jährige mit bestimmten Risikofaktoren ...
⬇️
https://www.apotheke-adhoc.de/nachrichten/detail/pharmazie/rsv-impfstoff-von-moderna-ab-sofort-erstattungsfaehig/#
RSV-Impfstoff von Moderna ab sofort erstattungsfähig | APOTHEKE ADHOC
Der RSV-Impfstoff mRESVIA von Moderna wird ab sofort für bestimmte Risikogruppen vollständig von den Krankenkassen erstattet. Empfohlen wird die Impfung für Menschen ab 75 Jahren sowie für 60- bis 74-...
www.apotheke-adhoc.de
July 24, 2025 at 5:54 PM
mRESVIA
#RSV -Impfstoff von Moderna ab sofort erstattungsfähig
Er kann regulär für Menschen ab 75 Jahren sowie für 60- bis 74-Jährige mit bestimmten Risikofaktoren ...
⬇️
https://www.apotheke-adhoc.de/nachrichten/detail/pharmazie/rsv-impfstoff-von-moderna-ab-sofort-erstattungsfaehig/#
#RSV -Impfstoff von Moderna ab sofort erstattungsfähig
Er kann regulär für Menschen ab 75 Jahren sowie für 60- bis 74-Jährige mit bestimmten Risikofaktoren ...
⬇️
https://www.apotheke-adhoc.de/nachrichten/detail/pharmazie/rsv-impfstoff-von-moderna-ab-sofort-erstattungsfaehig/#
The @ec.europa.eu has signed a Joint Procurement framework contract with Moderna, at the request of six participating countries, for access to up to 24 million doses of the RSV vaccine mRESVIA.
🔗👉 link.europa.eu/Yhb8wx
🔗👉 link.europa.eu/Yhb8wx
July 9, 2026 at 11:18 AM
The @ec.europa.eu has signed a Joint Procurement framework contract with Moderna, at the request of six participating countries, for access to up to 24 million doses of the RSV vaccine mRESVIA.
🔗👉 link.europa.eu/Yhb8wx
🔗👉 link.europa.eu/Yhb8wx
How about MResvia? I thought there wasn't a concern with that one.
January 7, 2025 at 11:10 PM
How about MResvia? I thought there wasn't a concern with that one.
the FDA just approved Moderna’s RSV vaccine (mRESVIA) for at-risk adults aged 18–59!
huge step in expanding protection beyond the 60+ population.
excited to see mRNA tech continue to deliver 💪
huge step in expanding protection beyond the 60+ population.
excited to see mRNA tech continue to deliver 💪
June 13, 2025 at 1:57 AM
the FDA just approved Moderna’s RSV vaccine (mRESVIA) for at-risk adults aged 18–59!
huge step in expanding protection beyond the 60+ population.
excited to see mRNA tech continue to deliver 💪
huge step in expanding protection beyond the 60+ population.
excited to see mRNA tech continue to deliver 💪
However: in contrast to the protein-based vaccines, mRESVIA does not demonstrate an increased risk of neurological adverse events like Guillain-Barre syndrome (GBS) and the mRNA platform as a whole has not either.
www.cdc.gov/mmwr/volumes...
This portends some messiness.
www.cdc.gov/mmwr/volumes...
This portends some messiness.
May 31, 2024 at 5:40 PM
However: in contrast to the protein-based vaccines, mRESVIA does not demonstrate an increased risk of neurological adverse events like Guillain-Barre syndrome (GBS) and the mRNA platform as a whole has not either.
www.cdc.gov/mmwr/volumes...
This portends some messiness.
www.cdc.gov/mmwr/volumes...
This portends some messiness.
Pharma News: U.S. FDA Approves Moderna's mRNA RSV Vaccine for Seniors, mRESVIA
www.thailandmedical.news/news/pharma-...
www.thailandmedical.news/news/pharma-...
Pharma News: U.S. FDA Approves Moderna's mRNA RSV Vaccine for Seniors, mRESVIA - Thailand Medical News
www.thailandmedical.news
June 2, 2024 at 11:43 PM
Pharma News: U.S. FDA Approves Moderna's mRNA RSV Vaccine for Seniors, mRESVIA
www.thailandmedical.news/news/pharma-...
www.thailandmedical.news/news/pharma-...
Der RSV-Impfstoff mRESVIA könnte der Beginn einer medizinischen Revolution sein. Jetzt wurde die Zulassung auf eine weitere Patientengruppe erweitert. Was das für euch bedeutet. docc.hk/zdgbtf
RSV-Saisonstart: Jede Menge Einzelfälle
Der RSV-Impfstoff mRESVIA könnte der Beginn einer medizinischen Revolution sein. Jetzt wurde die Zulassung auf eine weitere Patientengruppe erweitert. Was das für euch bedeutet.
docc.hk
September 29, 2025 at 12:15 PM
Der RSV-Impfstoff mRESVIA könnte der Beginn einer medizinischen Revolution sein. Jetzt wurde die Zulassung auf eine weitere Patientengruppe erweitert. Was das für euch bedeutet. docc.hk/zdgbtf
#Breaking The federal agency approved the company’s mRNA-1345 (mRESVIA) vaccine for people who are between the ages of 18-59. #IDsky #Medsky
FDA Expands Moderna’s mRNA-1345 RSV Vaccine to Younger Adults
The federal agency approved the company’s mRNA-1345 (mRESVIA) vaccine for people who are between the ages of 18-59.
www.contagionlive.com
June 13, 2025 at 12:52 PM